The 50% hemolysis rate tube assay, widely known as the CH50 test, is the reference functional method for quantifying the total hemolytic activity of the classical complement pathway in serum. By measuring complement-mediated lysis of antibody-sensitized sheep erythrocytes at the precise 50% hemolysis endpoint, the assay delivers high analytical precision for clinical immunology, biocompatibility evaluation, and biopharmaceutical development. This article covers the assay principle, sample requirements, procedural workflow, calculation methods, and typical applications.
Technical Overview
The 50% hemolysis rate tube assay, commonly designated the CH50 test (50% complement hemolysis), is a classic functional bioassay that measures the combined hemolytic activity of the complete classical complement cascade, from C1q through the terminal membrane attack complex (C5b-9). In the assay, patient or test serum is serially diluted and incubated with sheep erythrocytes that have been optimally sensitized with rabbit anti-sheep erythrocyte antibody (hemolysin). Active complement in the sample is activated via the classical pathway on the erythrocyte surface, forms membrane attack complexes, and lyses the cells, releasing hemoglobin into the supernatant. The released hemoglobin is quantified spectrophotometrically at approximately 541 nm, the absorption maximum of oxyhemoglobin.
The analytical rationale for selecting the 50% endpoint lies in the sigmoidal dose-response relationship between complement concentration and the percentage of cells lysed, described by the von Krogh equation. At the 50% hemolysis point, the curve reaches its maximum slope, meaning that a small change in complement concentration produces the largest measurable change in optical density. This makes the 50% endpoint the most precise and reproducible region of the response curve, whereas measurements near 0% or 100% lysis are insensitive to complement variation.
One CH50 unit is defined as the quantity of complement activity in 1 mL of undiluted serum that lyses 50% of a standardized suspension of approximately 5 × 10⁸ optimally antibody-sensitized sheep erythrocytes under fixed reaction conditions, typically 30 minutes of incubation at 37°C. Typical reference intervals for healthy adult serum fall in the range of 30 to 60 U/mL, although each laboratory must establish and verify its own population-based range. Methodological alignment with recognized guidance documents from organizations such as CLSI, WHO reference materials, and, in the context of blood-contacting products, ISO 10993-4 and ASTM F756, supports the transferability and regulatory acceptance of results from accredited third-party laboratories.
Testing Samples
Human Serum
Venous blood is collected by standard aseptic venipuncture into plain tubes without anticoagulant. The sample is allowed to clot at room temperature for 30 to 60 minutes and then centrifuged at approximately 1,500 to 2,000 × g for 10 to 15 minutes. Serum is separated promptly to prevent complement consumption or degradation during prolonged contact with the clot.
Animal Serum
Serum from rodent species (mouse, rat, guinea pig), rabbits, canines, and non-human primates is routinely tested in preclinical pharmacology and toxicology studies, as well as in infection and immunotoxicology research models. Species-specific considerations, such as naturally low classical pathway activity in certain strains, must be taken into account during interpretation.
Sample Handling and Stability Requirements
- Store serum at −70°C or below in single-use aliquots to preserve complement activity for extended periods.
- Avoid repeated freeze-thaw cycles, as each cycle progressively degrades complement activity and falsely lowers the CH50 value.
- Serum is strongly preferred over plasma: EDTA and citrate chelate the calcium and magnesium ions essential for classical pathway activation, and high concentrations of heparin can interfere with the reaction.
- Do not use heat-inactivated serum, grossly hemolyzed samples, or severely lipemic specimens, since pre-existing hemoglobin or turbidity interferes with absorbance readings at 541 nm.
- Complement-stabilizing collection tubes may be used for field collection or delayed processing when validated for this purpose.
Testing Items
The core deliverables of the 50% hemolysis rate tube assay include:
- Total classical pathway complement activity, reported as CH50 in U/mL or as CH100 equivalent units.
- Percent hemolysis determined at each serial serum dilution, providing the raw dose-response dataset.
- A qualitative interpretation of normal, reduced, or absent total complement activity relative to the laboratory reference interval.
- Optional paired AH50 (alternative pathway 50% hemolysis) testing to discriminate between classical, alternative, and terminal pathway defects.
- Correlative interpretation alongside antigenic C3 and C4 measurements to distinguish consumption from synthesis defects.
Testing Methods
Reagent Preparation
Sheep erythrocytes are washed three times in isotonic buffer and standardized to a defined cell suspension, commonly 1% to 2% in gelatin veronal-buffered saline containing calcium and magnesium ions (GVB²⁺) at pH 7.3 to 7.4. Rabbit hemolysin is titrated by checkerboard analysis to determine the dilution that yields optimal sensitization without antibody excess.
Cell Sensitization
Washed sheep erythrocytes are incubated with the optimal hemolysin dilution at 37°C for approximately 30 minutes with gentle mixing. The resulting antibody-sensitized cells, termed EA cells, are washed to remove unbound antibody and resuspended to the target concentration in GVB²⁺.
Tube Assay Procedure
- Prepare serial two-fold dilutions of the test serum in GVB²⁺ across a set of reaction tubes.
- Add a fixed volume of standardized EA cell suspension to each tube, maintaining a constant total reaction volume.
- Include a 0% hemolysis blank (EA cells plus buffer only) and a 100% hemolysis control (EA cells plus distilled water or saponin).
- Incubate all tubes at 37°C for 30 minutes with periodic gentle agitation to ensure uniform cell exposure.
- Terminate the reaction with cold saline and centrifuge to pellet unlysed cells.
- Measure the absorbance of each supernatant at 541 nm against the appropriate blanks.
Calculation and Result Interpretation
Percent hemolysis for each tube is calculated as the ratio of the sample absorbance, corrected for the blank, to the fully lysed 100% control. The data are then linearized using the von Krogh transformation, in which the value x/(1−x), where x is the fraction of cells lysed, is plotted against serum concentration or dilution. The interpolated point at which 50% hemolysis occurs corresponds to x equal to 0.5 and a transformed value of 1.0 on this linear plot. The CH50 value is derived from the reciprocal of the serum dilution or volume producing 50% hemolysis and is reported in U/mL. All specimens are analyzed in duplicate with predefined acceptance criteria, including control results within established limits and coefficient of variation thresholds, and a reference serum is included in each run to monitor assay drift.
Applications
The 50% hemolysis rate tube assay is applied across clinical, regulatory, and research settings:
- Clinical immunology screening for complement deficiencies in patients with recurrent pyogenic infections, invasive meningococcal or gonococcal disease, or unexplained autoimmune presentations.
- Monitoring of disease activity in immune complex disorders, including systemic lupus erythematosus, cryoglobulinemia, post-infectious glomerulonephritis, and membranoproliferative glomerulonephritis, where falling CH50 reflects active complement consumption.
- Pharmacodynamic monitoring of complement-inhibiting biologic therapies, where effective blockade drives functional CH50 activity toward undetectable levels.
- Biopharmaceutical development, including evaluation of complement activation-related risk for monoclonal antibodies, liposomal formulations, nanoparticles, and polymer-based therapeutics.
- Hemocompatibility and biocompatibility assessment programs for blood-contacting medical devices and biomaterials conducted in accordance with ISO 10993-4 principles.
- Immunotoxicology studies, vaccine immunogenicity research, and lot release testing of plasma-derived products and immunoglobulin preparations.
FAQ
Why is the endpoint set at 50% hemolysis rather than complete lysis?
The complement dose-response curve is sigmoidal, and its steepest, most linear region occurs at 50% lysis. At this point, small differences in complement activity produce the largest changes in measurable hemoglobin release, giving the assay its highest precision and sensitivity. Near 0% or 100% lysis, large changes in complement concentration produce negligible changes in absorbance.
What does a reduced CH50 result indicate?
A low CH50 indicates reduced functional activity of the classical pathway, which may reflect active complement consumption in immune complex disease, hereditary deficiency of a classical or terminal pathway component, severe hepatic synthetic failure, or sample handling artifacts such as delayed processing or repeated freeze-thaw cycles. Correlation with C3, C4, and AH50 results narrows the differential diagnosis.
Can plasma be used instead of serum?
Functional CH50 testing requires serum or a matrix with free divalent cations. EDTA and citrate plasma chelate calcium and magnesium, blocking classical pathway activation, and are therefore unsuitable for this assay even though they are valuable for markers of in vivo complement activation.
How long do samples remain stable?
Complement activity declines rapidly at room temperature, so serum should be separated within a few hours of collection. For longer storage, samples should be frozen at −70°C or below in single-use aliquots and shipped on dry ice to an accredited third-party laboratory.
What is a typical reference range?
Most laboratories report adult reference intervals of approximately 30 to 60 U/mL; however, values vary with methodology, reagent lots, and cell standardization. Each testing facility must establish and periodically verify its own reference interval for the populations it serves.